These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 12552444

  • 1. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP, Ahdieh-Grant L, Clayman B, Fox K, Massad LS, Cu-Uvin S, Shah KV, Anastos KM, Squires KE, Duerr A, Jamieson DJ, Burk RD, Klein RS, Minkoff H, Palefsky J, Strickler H, Schuman P, Piessens E, Miotti P.
    J Infect Dis; 2003 Jan 15; 187(2):194-205. PubMed ID: 12552444
    [Abstract] [Full Text] [Related]

  • 2. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP, Ahdieh-Grant L, Schneider MF, Clayman B, Massad LS, Anastos KM, Burk RD, Minkoff H, Palefsky J, Levine A, Strickler H.
    J Infect Dis; 2003 Dec 15; 188(12):1834-44. PubMed ID: 14673762
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
    Viscidi RP, Snyder B, Cu-Uvin S, Hogan JW, Clayman B, Klein RS, Sobel J, Shah KV.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 15; 14(1):283-8. PubMed ID: 15668510
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C, Coutlée F, Lapointe N, Simard P, Tran T, Samson J, Hum L.
    CMAJ; 1999 Jan 26; 160(2):185-91. PubMed ID: 9951439
    [Abstract] [Full Text] [Related]

  • 5. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):577-86. PubMed ID: 15840880
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM.
    J Infect Dis; 2001 Feb 01; 183(3):383-91. PubMed ID: 11133369
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K, DIANAIDS Collaborative Study Group.
    Int J STD AIDS; 2003 Jun 01; 14(6):417-25. PubMed ID: 12816671
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P, Rubí S, Lizano M, Carrillo A, Vilar-Compte D, García-Carrancá A, Sotelo R, García B, Sierra-Madero J, Mohar A.
    Gynecol Oncol; 2001 Jul 01; 82(1):27-31. PubMed ID: 11426958
    [Abstract] [Full Text] [Related]

  • 11. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE, Critchlow CW, Sow PS, Touré P, N'Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):100-9. PubMed ID: 16418512
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A, Heim K, Guger M, Ciresa-Kö Nig A, Christensen N, Sarcletti M, Wieland U, Pfister H, Zangerle R, Höpfl R.
    J Gen Virol; 2000 Mar 18; 81(Pt 3):701-8. PubMed ID: 10675407
    [Abstract] [Full Text] [Related]

  • 16. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Touré P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, Kuypers JM, Kiviat NB.
    J Infect Dis; 2003 Aug 15; 188(4):555-63. PubMed ID: 12898443
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence of human papillomavirus genotypes in women from three clinical settings.
    Chaturvedi AK, Dumestre J, Gaffga AM, Mire KM, Clark RA, Braly PS, Dunlap K, Beckel TE, Hammons AF, Kissinger PJ, Hagensee ME.
    J Med Virol; 2005 Jan 15; 75(1):105-13. PubMed ID: 15543579
    [Abstract] [Full Text] [Related]

  • 19. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
    Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK.
    Sex Transm Dis; 2009 May 15; 36(5):305-11. PubMed ID: 19295468
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.